Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer. [electronic resource]
- BMC cancer Feb 2016
- 168 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1471-2407
10.1186/s12885-016-2192-6 doi
Aged Aged, 80 and over Biomarkers, Tumor Combined Modality Therapy Gene Expression Humans Immunophenotyping Ki-67 Antigen--genetics Male Middle Aged Neoplasm Metastasis Neoplasm Staging Neoplastic Cells, Circulating--metabolism Prognosis Prostatic Neoplasms, Castration-Resistant--diagnosis Reproducibility of Results Vimentin--genetics